View Item 

Show simple item record

A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus

dc.contributor.authorRubenstein, Joel H.en_US
dc.contributor.authorDahlkemper, Anneen_US
dc.contributor.authorKao, John Y.en_US
dc.contributor.authorZhang, Minen_US
dc.contributor.authorMorgenstern, Halen_US
dc.contributor.authorMcMahon, Laurenceen_US
dc.contributor.authorInadomi, John M.en_US
dc.date.accessioned2010-06-01T19:43:04Z
dc.date.available2010-06-01T19:43:04Z
dc.date.issued2008-06en_US
dc.identifier.citationRubenstein, Joel H.; Dahlkemper, Anne; Kao, John Y.; Zhang, Min; Morgenstern, Hal; McMahon, Laurence; Inadomi, John M. (2008). "A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus." The American Journal of Gastroenterology 103(6): 1358-1364. <http://hdl.handle.net/2027.42/72851>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72851
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18510610&dopt=citationen_US
dc.format.extent122029 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 American College of Gastroenterology/Blackwell Publishingen_US
dc.titleA Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagusen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumAnn Arbor Veterans Affairs Medical Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arbor, Michiganen_US
dc.contributor.affiliationumUniversity of Michigan School of Public Health, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherGI Health Outcomes, Policy and Economics (HOPE) Research Program, University of California, San Francisco, and the San Francisco General Hospital, San Francisco, Californiaen_US
dc.identifier.pmid18510610en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72851/1/j.1572-0241.2008.01823.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2008.01823.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceEl-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002; 50: 368 – 72.en_US
dc.identifier.citedreferenceLagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825 – 31.en_US
dc.identifier.citedreferenceSampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888 – 95.en_US
dc.identifier.citedreferencePortale G, Peters JH, Hagen JA, et al. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without Barrett mucosa. Arch Surg 2005; 140: 570 – 4.en_US
dc.identifier.citedreferenceHampel H, Abraham NS, El-Serag HB. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199 – 211.en_US
dc.identifier.citedreferenceWong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005; 3: 1 – 10.en_US
dc.identifier.citedreferenceLa Vecchia C, Negri E, Lagiou P, et al. Oesophageal adenocarcinoma: A paradigm of mechanical carcinogenesis? Int J Cancer 2002; 102: 269 – 70.en_US
dc.identifier.citedreferenceLagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 2006; 7: 347 – 9.en_US
dc.identifier.citedreferenceCorley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 34 – 41; quiz 311.en_US
dc.identifier.citedreferenceEl-Serag HB, Kvapil P, Hacken-Bitar J, et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005; 100: 2151 – 6.en_US
dc.identifier.citedreferenceEdelstein ZR, Farrow DC, Bronner MP, et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403 – 11.en_US
dc.identifier.citedreferenceChen SC, Chou CK, Wong FH, et al. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. Cancer Res 1991; 51: 1898 – 903.en_US
dc.identifier.citedreferenceLiu YC, Leu CM, Wong FH, et al. Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells. J Biomed Sci 2002; 9: 665 – 74.en_US
dc.identifier.citedreferenceFesta A, D'Agostino R Jr, Tracy RP, et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 1131 – 7.en_US
dc.identifier.citedreferenceSomasundar P, Riggs D, Jackson B, et al. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg 2003; 186: 575 – 8.en_US
dc.identifier.citedreferenceStattin P, Lukanova A, Biessy C, et al. Obesity and colon cancer: Does leptin provide a link? Int J Cancer 2004; 109: 149 – 52.en_US
dc.identifier.citedreferencede Martel C, Haggerty TD, Corley DA, et al. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007; 102: 1166 – 72.en_US
dc.identifier.citedreferenceKelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: A systematic review. Br J Cancer 2006; 94: 1221 – 5.en_US
dc.identifier.citedreferenceArita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79 – 83.en_US
dc.identifier.citedreferenceYildiz BO, Suchard MA, Wong ML, et al. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A 2004; 101: 10434 – 9.en_US
dc.identifier.citedreferenceShea SA, Hilton MF, Orlova C, et al. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab 2005; 90: 2537 – 44.en_US
dc.identifier.citedreferenceBottner A, Kratzsch J, Muller G, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004; 89: 4053 – 61.en_US
dc.identifier.citedreferenceGavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. J Clin Endocrinol Metab 2003; 88: 4823 – 31.en_US
dc.identifier.citedreferencePischon T, Hotamisligil GS, Rimm EB. Adiponectin: Stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003; 49: 650 – 2.en_US
dc.identifier.citedreferenceLagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883 – 90.en_US
dc.identifier.citedreferenceFesta A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42 – 7.en_US
dc.identifier.citedreferenceErlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291: 585 – 90.en_US
dc.identifier.citedreferenceChak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006; 107: 2160 – 6.en_US
dc.identifier.citedreferenceBuskens CJ, Hulscher JB, van Gulik TM, et al. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res 2006; 135: 337 – 44.en_US
dc.identifier.citedreferenceJeon J, Luebeck EG, Moolgavkar SH. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Control 2006; 17: 971 – 81.en_US
dc.identifier.citedreferenceMaeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286 – 9.en_US
dc.identifier.citedreferenceOtake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance. Clin Cancer Res 2005; 11: 3642 – 6.en_US
dc.identifier.citedreferenceWei EK, Giovannucci E, Fuchs CS, et al. Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study. J Natl Cancer Inst 2005; 97: 1688 – 94.en_US
dc.identifier.citedreferenceWang Y, Lam K, Xu J, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in oligomerization-dependent manner. J Biol Chem 2005; 280: 18341 – 7.en_US
dc.identifier.citedreferenceWulster-Radcliffe MC, Ajuwon KM, Wang J, et al. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004; 316: 924 – 9.en_US
dc.identifier.citedreferenceSouza RF, Shewmake KL, Shen Y, et al. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus. Am J Gastroenterol 2005; 100: 551 – 9.en_US
dc.identifier.citedreferenceLazar MA. How obesity causes diabetes: Not a tall tale. Science 2005; 307: 373 – 5.en_US
dc.identifier.citedreferenceYokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723 – 32.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2008.01823.x.pdf
Size:
119.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.